Gene · 338399
Papers2,833
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,833
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Research progress on the role of extracellular vesicles in neurodegenerative diseases. | Transl Neurodegener | 2023 | 37697342 | PubTator, text mining | PubMed |
| Two Distinct Deleterious Causative Variants in a Family with Multiple Cancer-Affected Patients. | Adv Biomed Res | 2023 | 37694253 | PubTator, text mining | PubMed |
| Implication of the cooking oil-peroxidation product "hydroxynonenal" for Alzheimer's disease. | Front Aging Neurosci | 2023 | 37693644 | PubTator, text mining | PubMed |
| Feeding High-Fat Diet Accelerates Development of Peripheral and Central Insulin Resistance and Inflammation and Worsens AD-like Pathology in APP/PS1 Mice. | Nutrients | 2023 | 37686722 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression. | J Evid Based Integr Med | 2023 | 37654084 | PubTator, text mining | PubMed |
| EVs-mediated delivery of CB2 receptor agonist for Alzheimer's disease therapy. | Asian J Pharm Sci | 2023 | 37645682 | PubTator, text mining | PubMed |
| A review of anti-tumour effects of Ganoderma lucidum in gastrointestinal cancer. | Chin Med | 2023 | 37641070 | PubTator, text mining | PubMed |
| Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective. | Front Neurosci | 2023 | 37638319 | PubTator, text mining | PubMed |
| "It Doesn't Cure, but It Protects": COVID-19 Vaccines through the Eyes of Children and Their Parents. | Vaccines (Basel) | 2023 | 37631873 | PubTator, text mining | PubMed |
| Aerobic Exercise Facilitates the Nuclear Translocation of SREBP2 by Activating AKT/SEC24D to Contribute Cholesterol Homeostasis for Improving Cognition in APP/PS1 Mice. | Int J Mol Sci | 2023 | 37629027 | PubTator, text mining | PubMed |
| BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets. | Int J Mol Sci | 2023 | 37628785 | PubTator, text mining | PubMed |
| A Study of Maternal Patients Diagnosed with Inborn Errors of Metabolism Due to Positive Newborn Mass Screening in Their Newborns. | Children (Basel) | 2023 | 37628339 | PubTator, text mining | PubMed |
| Integrated Multi-Omics Analysis for Inferring Molecular Players in Inclusion Body Myositis. | Antioxidants (Basel) | 2023 | 37627634 | PubTator, text mining | PubMed |
| L-serine: Neurological Implications and Therapeutic Potential. | Biomedicines | 2023 | 37626614 | PubTator, text mining | PubMed |
| Corticospinal Adaptation to Short-Term Horizontal Balance Perturbation Training. | Brain Sci | 2023 | 37626565 | PubTator, text mining | PubMed |
| Stratified microbial communities in Australia's only anchialine cave are taxonomically novel and drive chemotrophic energy production via coupled nitrogen-sulphur cycling. | Microbiome | 2023 | 37626351 | PubTator, text mining | PubMed |
| Metabolic Profile of Alzheimer's Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster? | Metabolites | 2023 | 37623897 | PubTator, text mining | PubMed |
| Investigating Planning and Non-Targeted Exploration in PIAAC 2012: Validating Their Measures Based on Process Data and Investigating Their Relationships with Problem-Solving Competency. | J Intell | 2023 | 37623539 | PubTator, text mining | PubMed |
| The Deficits of Insulin Signal in Alzheimer's Disease and the Mechanisms of Vanadium Compounds in Curing AD. | Curr Issues Mol Biol | 2023 | 37623221 | PubTator, text mining | PubMed |
| An Exosome-Based Therapeutic Strategy Targeting Neuroinflammation in Alzheimer's Disease with Berberine and Palmatine. | Drug Des Devel Ther | 2023 | 37609432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/338399/papers?page=14